Hospital Stocks Rise Up to 5% After 30% Cap on Cancer Drug Margins
Hospital stocks including Apollo Hospitals and Max Healthcare rose up to 5% after the government capped trade margins on non-scheduled anti-cancer drugs at 30%, potentially lowering medicine prices by 70%. Analysts Jefferies and Emkay expect manageable earnings impacts despite short-term margin pressures. Jefferies favors Fortis, Manipal, Apollo, Max Healthcare, and Medanta due to strong demand and attractive valuations.
ET Markets·



